Starts in 4 weeks from now
LocationOnline and on-site
This joint event by the ERC and the European Parliament's Panel for the Future of Science and Technology (STOA) builds on an ERC report showcasing pioneering projects that address the urgent transformations needed to tackle climate change and rising social inequality.
The event will delve into the essential conditions that enable fair and inclusive green transitions and the Clean Industrial Deal, an ambitious European Commission initiative aimed at decarbonising EU industry while boosting competitiveness and ensuring energy affordability for all.
Researchers will share groundbreaking insights and real-world solutions illustrating how governments, businesses and communities are driving the shift toward a more sustainable future. Key stakeholders will join the discussion to explore strategies for enhancing the integration of scientific evidence into policymaking, ensuring science directly informs decisions for maximum impact.
The programme and link to the webcast are available in the announcement on the website of the ERC.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.